Revised SPCs: Vimpat (lacosamide) – all products

SPCs revised to include license extension as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients with idiopathic generalized epilepsy aged 4 years and older.

Source:

electronic Medicines compendium